In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Deletion of multidrug resistance-associated protein 1 improves endothelial function and attenuates atherosclerosis in MRP1-/- LDL-/- double knockout mice

Session Best Posters 6

Speaker Julian Jehle

Event : ESC Congress 2017

  • Topic : basic science
  • Sub-topic : Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis
  • Session type : Best ePosters

Authors : J Jehle (Bonn,DE), CFH Mueller (Bonn,DE), A Aksoy (Bonn,DE), S Zimmer (Bonn,DE), G Nickenig (Bonn,DE), V Tiyerili (Bonn,DE)

J. Jehle1 , C.F.H. Mueller1 , A. Aksoy1 , S. Zimmer1 , G. Nickenig1 , V. Tiyerili1 , 1University Hospital Bonn, Department of Cardiology - Bonn - Germany ,

Vascular Biology - Atherosclerosis

European Heart Journal ( 2017 ) 38 ( Supplement ), 1070

Background: Multidrug resistance-associated protein 1 (MRP1) is an anion transporter which is implicated in the efflux of the intracellular antioxidant anion glutathione (GSH), as well as leukotrienes (LT). Pharmacological inhibition of MRP1 exhibits antioxidative and antiatherosclerotic effects both, in vitro and in vivo. However, pharmacological inhibitors of MRP1 lack selectivity which prompted us to study the in vivo impact of a genetic disruption of MRP1 on endothelial dysfunction, reactive oxygen species formation and atherogenesis in an atherosclerotic mouse model.

Methods: We crossed atherosclerosis-prone LDL−/− mice and MRP1−/− mice of FVB origin to generate MRP1−/− LDL−/− double knockout mice. These mice were fed a high-fat and cholesterol-rich diet for 7 weeks. Hereafter, endothelial function was assessed in isolated aortic rings. Reactive oxygen species were quantified by L-012 chemiluminescence and the atherosclerotic plaque burden was measured following oil red O staining. GSH and LTC4 levels were measured in murine plasma and aortic tissue by fluorometric assays.

Results: Arterial blood pressure was significantly reduced in MRP1−/− LDL−/− double knockout mice compared to single knockout controls (SBP: 93±5 mmHg vs. 128±4 mmHg; p<0.001; DBP: 56±3 mmHg vs. 84±3 mmHg; p<0.001). Furthermore, endothelium-dependent vasodilation of MRP1−/− LDL−/− double knockout mice yielded 44% and was significantly improved compared to MRP1-competent LDL−/− single knockout mice which yielded 22% (p<0.05). This improvement was accompanied by a significant reduction in reactive oxygen species formation within the aortic tissue (102±27 RLU/s/mg vs. 315±78 RLU/s/mg; p<0.05). Moreover, the atherosclerotic plaque burden of MRP1−/− LDL−/− double knockout mice was significantly diminished (0.06±0.01 vs. 0.12±0.02; p<0.05). Finally, the ratio of aortic to plasma GSH levels was markedly increased in MRP-1−/− LDL−/− double knockout mice (96±21 vs. 49±10; p=0.08) and aortic LTC4 levels were significantly decreased (725±159 pg/mg protein vs. 1480±145 pg/mg protein; p<0.01).

Conclusion: MRP1 appears to disturb cellular redox balance since its genetic disruption reduces arterial blood pressure and vascular oxidative stress in vivo. Impairment of MRP-1 action leads to an improved endothelial function and a reduced plaque burden in atherosclerotic mice. Therefore, MRP1 might represent a promising therapeutic target to improve endothelial function in patients suffering from atherosclerosis.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are